Advertisement

Topics

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours

20:14 EDT 30 Jun 2017 | Nature Publishing

Original Article: A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours

NEXT ARTICLE

More From BioPortfolio on "A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours"

Advertisement
Quick Search
Advertisement
Advertisement